Pullulan in biomedical research and development - A review

Int J Biol Macromol. 2021 Jan 1:166:694-706. doi: 10.1016/j.ijbiomac.2020.10.227. Epub 2020 Nov 1.

Abstract

Pullulan is an imperative microbial exo-polymer commercially produced by yeast like fungus Aureobasidium pullulans. Its structure contains maltosyl repeating units which comprises two α-(1 → 4) linked glucopyranose rings attached to one glucopyranose ring through α-(1 → 6) glycosidic bond. The co-existence of α-(1 → 6) and α-(1 → 4) glycosidic linkages endows distinctive physico-chemical properties to pullulan. It is highly biocompatible, non-toxic and non-carcinogenic in nature. It is extremely resistant to any mutagenicity or immunogenicity. The unique properties of pullulan make it a potent candidate for biomedical applications viz. drug delivery, gene delivery, tissue engineering, molecular chaperon, plasma expander, vaccination, etc. This review highlights the potential of pullulan in biomedical research and development.

Keywords: Biomedical industry; Pharmaceutical industry; Pullulan.

Publication types

  • Review

MeSH terms

  • Animals
  • Blood Substitutes / chemistry
  • Drug Carriers / chemistry*
  • Gene Transfer Techniques
  • Glucans / chemistry*
  • Humans
  • Tissue Scaffolds / chemistry*
  • Vaccination / methods

Substances

  • Blood Substitutes
  • Drug Carriers
  • Glucans
  • pullulan